Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Terpinen-4-ol is a terpineol that is 1-menthene carrying a hydroxy substituent at position 4. It is a colorless or pale yellow liquid with a spicy, nutmeg-like, woody-earthy, and also lilac-like odor. Terpinen-4-ol is a potent bactericidal agent that possesses antifungal properties and is a primary active ingredient of tea tree oil (TTO). It is found in a variety of aromatic plants, such as oranges, mandarins, origanum, New Zealand lemonwood tree, Japanese cedar, and black pepper.

562-74-3

Post Buying Request

562-74-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

562-74-3 Usage

Uses

Used in Antimicrobial Applications:
Terpinen-4-ol is used as a potent bactericidal agent for its antifungal properties. It is particularly effective against Staphylococcus aureus and C. albicans, and when combined with conventional drugs, it may help treat resistant yeast and bacterial infections.
Used in Anticancer Applications:
Terpinen-4-ol is used as an anticancer agent for inducing antitumor effects by selectively causing necrotic cell death and cell-cycle arrest in melanoma cell lines, or by triggering caspase-dependent apoptosis in human melanoma cells, particularly in drug (Adriamycin) resistant cells. It also elicits a dose-dependent cytotoxic response on human non-small cell lung cancer cells, presumably through the involvement of the mitochondrial apoptotic pathway.
Used in Perfumery and Fragrance Industry:
Terpinen-4-ol is used as a key component in artificial geranium and pepper oils and in perfumery for creating herbaceous and lavender notes.
Used in Flavor and Food Industry:
Terpinen-4-ol is used for its taste characteristics at 30 ppm, which are sweet, citrus green with a tropical fruity character. It is found in fresh apple, apricots, orange juice, and peel oils of orange, lemon, grapefruit, tangerines, anise, cinnamon, ginger, and nutmeg.
Used in Pharmaceutical Industry:
Terpinen-4-ol is used as a pharmaceutical candidate due to its antimicrobial, anti-viral, anti-fungal, anti-oxidant, anti-inflammatory, and anti-cancer activities. It is a major plant-derived secondary metabolite widely found in natural products, including fruits, vegetables, and herbs, and is known to be associated with plant defense mechanisms.

Biological activities

Terpinen-4-ol contained in TTO confers its various biological effects. Terpinen-4-ol is the major active component of tea tree oil. Terpinen-4-ol gained attention because of its antibacterial, antifungal, antiviral, and anti-inflammatory properties. Antibacterial activity erpinen-4-ol contained in TTO confers its remarkable antibacterial activity. Most bacteria are susceptible to TTO at concentrations of 1.0% or less; MICs in excess of 2% have been reported for organisms such as commensal skin staphylococci and micrococci, Enterococcus faecalis, and Pseudomonas aeruginosa[18]. TTO is for the most part bactericidal in nature, although it may be bacteriostatic at lower concentrations. The activity of TTO against antibiotic-resistant bacteria has attracted considerable interest, with methicillin-resistant Staphylococcus aureus (MRSA) receiving the most attention thus far. Since the potential to use TTO against MRSA was first hypothesized[19], several groups have evaluated the activity of TTO against MRSA, beginning with Carson et al.[20]?who examined 64 MRSA isolates from Australia and the United Kingdom, including 33 mupirocin-resistant isolates. When the effects of terpinen-4-ol on S. aureus were examined, none was found to induce autolysis but was found to cause the leakage of 260-nmlightabsorbing material and to render cells susceptible to sodium chloride[21]. Electron microscopy of terpinen-4-ol-treated S. aureus cells revealed lesions similar to those seen after TTO treatment[22], including mesosome-like structures. In summary, the loss of intracellular material, inability to maintain homeostasis, and inhibition of respiration after treatment with terpinen-4-ol is consistent with a mechanism of action involving the loss of membrane integrity and function. Antiprotozoal activity Two publications show that TTO has antiprotozoal activity. TTO caused a 50% reduction in growth (compared to controls) of the protozoa Leishmania major and Trypanosoma brucei at concentrations of 403 mg/ml and 0.5 mg/ml, respectively[23]. In another study, TTO at 300 mg/ml killed all cells of Trichomonas vaginalis. There is also anecdotal in vivo evidence that TTO may be effective in treating Trichomonas vaginalis infections[24]. Further investigation showed that terpinen-4-ol contributed significantly to this activity. Anti-Mites activity It has been reported that lid scrub with different concentrations of TTO is effective in reducing Demodex mite counts and ocular surface inflammation associated with blepharitis, conjunctivitis, and keratitis[25, 26]. Terpinen-4-ol is the most active ingredient in TTO in exerting Demodex mite-killing effects. Anti-inflammatory activity Numerous recent studies now support the anecdotal evidence attributing anti-inflammatory activity to TTO. In vitro work over the last decade has demonstrated that TTO affects a range of immune responses, both in vitro and in vivo. It can inhibit the lipopolysaccharide-induced production of the inflammatory mediators tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-10 by human peripheral blood monocytes and that of prostaglandin E2. Terpinen-4-ol plays a major role in the anti-inflammatory effect of TTO. Terpinen-4-ol was able to diminish the production of TNF--alpha, IL-1 beta, IL-8, IL-10, and prostaglandin E2 by lipopolysaccharide-activated monocytes. Terpinen-4-ol also suppressed superoxide production by agonist-stimulated monocytes but not neutrophils[27]. TTO failed to suppress the adherence reaction of neutrophils induced by TNF-alpha stimulation or the casein-induced recruitment of neutrophils into the peritoneal cavities of mice. These studies identify specific mechanisms by which TTO may act in vivo to diminish the normal inflammatory response. In vivo, topically applied TTO has been shown to modulate the edema associated with the efferent phase of a contact hypersensitivity response in mice[28] but not the development of edema in the skin of nonsensitized mice or the edematous response to UVB exposure. This activity was attributed primarily to terpinen-4-ol. TTO and terpinen-4-ol applied after histamine injection reduced histamine-induced skin edema, and TTO also significantly reduced swelling induced by intradermal injection of compound 48/80[29]. Work has now shown that terpinen-4-ol modulates the vasodilation and plasma extravasation associated with histamine-induced inflammation in humans. Anti-cancer The anticancer effects of terpinen-4-ol are impressive in various types of cancer cells both in vitro and in vivo. Terpinen-4-ol is a major component of essential oil derived from several aromatic plants. It is used as an anti-inflammatory and antioxidant agent[15–17]. The contribution of terpinen-4-ol as an anti-cancer agent and the underlying signaling pathways of different types of cell death are unknown. Herein, it is shown that the mechanism of action of terpinen-4-ol is induction of apoptosis and not necrosis. It is also shown that terpinen-4-ol and various anticancer agents demonstrate a synergistic growth inhibitory effect by decreasing the survival of various cancer cell lines. Such combinations maybe expected to be more effective and less toxic since lower drug concentrations can be used for treating a wide range of cancers. Injection of terpinen-4-ol into the tumor remarkably inhibited tumor growth without any significant adverse effects. In search for more convenient routes of administration, two pharmaceutical formulations were prepared and tested for systemic administration, nano formulation and suspension. Nano formulations increased the surface area and therefore dramatically improved water solubility, bioavailability, effectiveness and efficiency. The suspension form was composed of small drops/molecules of the therapeutically active ingredient (the oil) in a suspension medium. Since the nanodrops were associated with serious toxicity (loss of body weight, mortality), the suspension approach that was devoid of any side effects was chosen for further exploration. The systemic administration of terpinen-4-ol by suspension was associated with a significant reduction in tumor size in the experimental nude mice.

References

Martin KW, Ernst E (2004) Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials. Mycoses 47: 87–92. Calcabrini A, Stringaro A, Toccacieli L, Meschini S, Marra M, Colone M, et al. (2004) Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells. J Invest Dermatol 122: 349–360. Arweiler NB, Donos N, Netuschil L, Reich E, Sculean A (2000) Clinical and antibacterial effect of tea tree oil—a pilot study. Clin Oral Investig 4: 70–73. Gershenzon J, Dudareva N (2007) The function of terpene natural products in the natural world. Nat Chem Biol 3: 408–414. PMID: 17576428 Wagner KH, Elmadfa I (2003) Biological relevance of terpenoids. Overview focusing on mono-, diand tetraterpenes. Ann Nutr Metab 47: 95–106. PMID: 12743459 Gould MN (1997) Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect 105 Suppl 4: 977–979. PMID: 9255590 Da Fonseca CO, Masini M, Futuro D, Caetano R, Gattass CR, Quirico-Santos T (2006) Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review. Surg Neurol 66: 611–615. PMID: 17145324 da Fonseca CO, Schwartsmann G, Fischer J, Nagel J, Futuro D, Quirico-Santos T, et al. (2008) Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. Surg Neurol 70: 259–266; discussion 266–257. Sobral Marianna Vieira X AL, Lima Tamires Cardoso, and de Sousa Dami?o Pergentino (2014) Antitumor Activity of Monoterpenes Found in Essential Oils. The Scientific World Journal 2014. Pino JA, Marbot R, Fuentes V (2003) Journal of Agricultural and Food Chemistry 51: 3836–3839. Loughlin R, Gilmore BF, McCarron PA, Tunney MM (2008). Lett Appl Microbiol 46: 428–433. doi: 10.1111/j.1472-765X.2008.02334.x Mondello F, De Bernardis F, Girolamo A, Cassone A, Salvatore G (2006) BMC Infect Dis 6: 158. Dryden MS, Dailly S, Crouch M (2004) J Hosp Infect 56: 283–286. Mertas A, Garbusinska A, Szliszka E, Jureczko A, Kowalska M, KrolW(2015) Biomed Res Int 2015: 590470. doi: 10.1155/2015/590470 Greay SJ, Ireland DJ, Kissick HT, Levy A, Beilharz MW, Riley TV, et al. (2010) Cancer Chemother Pharmacol 65: 877–888. Calcabrini A, Stringaro A, Toccacieli L, Meschini S, Marra M, Colone M, et al. (2004) Terpinen-4-ol, The Main Component of Melaleuca Alternifolia (Tea Tree) Oil Inhibits the In Vitro Growth of Human Melanoma Cells. J Investig Dermatol 122: 349–360. Wu CS, Chen YJ, Chen JJ, Shieh JJ, Huang CH, Lin PS, et al. (2012) Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo. Evid Based Complement Alternat Med 2012: 818261. doi: 10.1155/2012/818261 Banes-Marshall, L., P. Cawley, and C. A. Phillips. 2001. Br. J. Biomed. Sci. 58:139–145. Walsh, L. J., and J. Longstaff. 1987. The antimicrobial effects of an essential oil on selected oral pathogens. Periodontology 8:11–15. Carson, C. F., B. D. Cookson, H. D. Farrelly, and T. V. Riley. 1995. Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J. Antimicrob. Chemother. 35:421–424. Carson, C. F., B. J. Mee, and T. V. Riley. 2002. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob. Agents Chemother. 48:1914–1920. Reichling, J., A. Weseler, U. Landvatter, and R. Saller. 2002. Bioactive essential oils used in phytomedicine as antiinfective agents: Australian tea tree oil and manuka oil. Acta Phytotherapeutica 1:26–32. Mikus, J., M. Harkenthal, D. Steverding, and J. Reichling. 2000. In vitro effect of essential oils and isolated monoand sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med. 66:366–368. Pen?a, E. F. 1962. Melaleuca alternifolia oil—its use for trichomonal vaginitis and other vaginal infections. Obstet. Gynecol. 19:793–795. Gao YY, Di Pascuale M, Li W, et al. High prevalence of Demodex in eye lashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 2005; 46: 3094–3098. Liu J, Sheha H, Tseng SCG. Pathogenic role of Demodex mites in blepharitis. Curr Opin Allergy Clin Immunol. 2010; 10: 505–510. Brand, C., A. Ferrante, R. H. Prager, T. V. Riley, C. F. Carson, J. J. Finlay-Jones, and P. H. Hart. 2001. The water soluble-components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm. Res. 50:213–219. Brand, C., M. A. Grimbaldeston, J. R. Gamble, J. Drew, J. J. Finlay-Jones, and P. H. Hart. 2002. Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response. Inflamm. Res. 51:236–244. Brand, C., S. L. Townley, J. J. Finlay-Jones, and P. H. Hart. 2002. Tea tree oil reduces histamine-induced oedema in murine ears. Inflamm. Res. 51: 283–289.

Flammability and Explosibility

Notclassified

Biochem/physiol Actions

Taste at 30 ppm

Anticancer Research

Also this molecule exhibits antitumor effects by apoptotic mechanism. Studies weredone in mice bearing A549 tumor xenografts (Quintans et al. 2013; Kiyan et al.2014).

Synthesis

One of several terpinenol isomers, depending on the position of the double bond and that of the hydroxyl group, this terpene, whose structure has been defined by Wallach, can be isolated by fractional distillation. It exists in nature as the dextro, levo and racemic isomer; the synthetic product is always optically inactive. The 1-terpineneol or 1-meththyl-4-isopropyl-3-cyclohexen-1-ol has been prepared by Wallach (Burdock, 1997).

Check Digit Verification of cas no

The CAS Registry Mumber 562-74-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,6 and 2 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 562-74:
(5*5)+(4*6)+(3*2)+(2*7)+(1*4)=73
73 % 10 = 3
So 562-74-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H18O/c1-8(2)10(11)6-4-9(3)5-7-10/h4,8,11H,5-7H2,1-3H3

562-74-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T1993)  (±)-Terpinen-4-ol  >95.0%(GC)

  • 562-74-3

  • 25mL

  • 460.00CNY

  • Detail
  • Sigma-Aldrich

  • (03900590)  Terpinen4-ol  primary pharmaceutical reference standard

  • 562-74-3

  • 03900590-50MG

  • 1,930.50CNY

  • Detail

562-74-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-terpineol

1.2 Other means of identification

Product number -
Other names p-menth-1-en-4-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Fragrances
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:562-74-3 SDS

562-74-3Synthetic route

4-methyl-1-isopropenylcyclohex-3-en-1-ol
3419-02-1

4-methyl-1-isopropenylcyclohex-3-en-1-ol

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Conditions
ConditionsYield
With hydrogen In water; ethyl acetate at 50℃; under 75.0075 Torr; for 5h; Solvent; Concentration; Temperature; Large scale;97.8%
(1-Isopropyl-4-methyl-cyclohex-3-enyloxymethoxy)-dimethyl-(1,1,2-trimethyl-propyl)-silane
125816-48-0

(1-Isopropyl-4-methyl-cyclohex-3-enyloxymethoxy)-dimethyl-(1,1,2-trimethyl-propyl)-silane

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran for 2.5h; Product distribution; Ambient temperature; cleavage with Et4NF in MeCN; cleavage of acetals with tetraalkylammonium fluoride salts; protection and deprotection of alcohols with chloromethoxysilanes;78%
2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene
4584-23-0

2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene

A

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

B

4-methyl-1-isopropenylcyclohex-3-en-1-ol
3419-02-1

4-methyl-1-isopropenylcyclohex-3-en-1-ol

Conditions
ConditionsYield
With hydrogen In ethyl acetate at 25 - 125℃; under 3750.38 Torr; for 24h; Temperature; Reagent/catalyst; Solvent; Time; Autoclave; Inert atmosphere; Overall yield = 82.7 %;A 8.3%
B 74.4%
2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene
4584-23-0

2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene

A

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

B

terpineol
98-55-5

terpineol

Conditions
ConditionsYield
With lithium aluminium tetrahydride; aluminium trichloride In diethyl ether for 8h; Ambient temperature;A 67%
B 22%
With lithium In ethylenediamine for 0.5h;A 36%
B 60%
Acetic acid (Z)-3,7-dimethyl-6-oxo-oct-2-enyl ester
105273-31-2

Acetic acid (Z)-3,7-dimethyl-6-oxo-oct-2-enyl ester

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Conditions
ConditionsYield
With samarium diiodide; tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran for 3h; Heating;62%

A

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

B

2-methyl-5-(1-methylethyl)-(1α,2α,5α)-bicyclo[3.1.0]hexan-2-ol
3484-42-2

2-methyl-5-(1-methylethyl)-(1α,2α,5α)-bicyclo[3.1.0]hexan-2-ol

C

trans-sabinene hydrate

trans-sabinene hydrate

Conditions
ConditionsYield
With Penicillium paxilli In dimethyl sulfoxide at 28 - 30℃; for 120h; Reagent/catalyst; Microbiological reaction;A 56%
B 3%
C 13%
With Fusarium concentricum In dimethyl sulfoxide at 28 - 30℃; for 120h; Reagent/catalyst; Microbiological reaction;A 30%
B 21%
C 17%
1,4-cineole
470-67-7

1,4-cineole

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Conditions
ConditionsYield
With n-butyllithium; potassium tert-butylate In hexane at 60℃; for 40h;50%
2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene
4584-23-0

2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene

A

Terpinolene
586-62-9

Terpinolene

B

p-cymene-8-ol
1197-01-9

p-cymene-8-ol

C

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

D

terpineol
98-55-5

terpineol

Conditions
ConditionsYield
With sodium In tetrahydrofuran at 65℃; for 12h;A 4%
B 16%
C 48%
D 26%
Conditions
ConditionsYield
With formic acid Verseifen des Formiats; dextrorotatory terpinenol-(4);

A

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

B

terpin-4-ol
91008-90-1

terpin-4-ol

Conditions
ConditionsYield
With sulfuric acid dextrorotatory terpinenol-(4);
2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene
4584-23-0

2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene

A

1-methyl-4-isopropenylbenzene
1195-32-0

1-methyl-4-isopropenylbenzene

B

p-cymene-8-ol
1197-01-9

p-cymene-8-ol

C

4-methylisopropylbenzene
99-87-6

4-methylisopropylbenzene

D

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran at 66℃; for 7.5h; Further byproducts given. Title compound not separated from byproducts;
2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene
4584-23-0

2,2,6-trimethyl-1-oxa-spira[2.5]oct-ene

A

1-methyl-4-isopropenylbenzene
1195-32-0

1-methyl-4-isopropenylbenzene

B

p-cymene-8-ol
1197-01-9

p-cymene-8-ol

C

4-methylisopropylbenzene
99-87-6

4-methylisopropylbenzene

D

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

E

p-mentha-1,4-dien-8-ol
53312-55-3

p-mentha-1,4-dien-8-ol

F

1-(1'-hydroxy-1'-methylethyl)-4-methylcyclohexa-1,3-diene
82538-84-9

1-(1'-hydroxy-1'-methylethyl)-4-methylcyclohexa-1,3-diene

Conditions
ConditionsYield
With potassium tert-butylate In dimethyl sulfoxide at 27℃; for 0.75h; Product distribution; var. solvents and temp.;
1,4-dichloro-p-menthane
27621-71-2

1,4-dichloro-p-menthane

KOH-solution

KOH-solution

A

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

B

γ-terpineol
586-81-2

γ-terpineol

Conditions
ConditionsYield
at 100℃; trans-form;
Conditions
ConditionsYield
levorotatory form;
dextrorotatory sabinene hydrate

dextrorotatory sabinene hydrate

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Conditions
ConditionsYield
With sulfuric acid dextrorotatory terpinenol-(4);
terpin-4-ol
91008-90-1

terpin-4-ol

A

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

B

1.4-oxido-p-menthane

1.4-oxido-p-menthane

Conditions
ConditionsYield
With oxalic acid inactive terpinenol-(4);
1,4-dichloro-trans-p-menthane
25570-95-0

1,4-dichloro-trans-p-menthane

A

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

B

terpinene

terpinene

Conditions
ConditionsYield
With potassium hydroxide at 50 - 100℃; inactive terpinenol-(4);
1,4-cineole
470-67-7

1,4-cineole

limonene.
138-86-3

limonene.

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Conditions
ConditionsYield
With anthracene; sodium In water
geranyl diphosphate
763-10-0

geranyl diphosphate

A

Geraniol
106-24-1

Geraniol

B

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Conditions
ConditionsYield
With 6His-tagged Pseudomonas fluorescens PfO-1 Pfl_1841 2-methylenebornane synthase In pentane at 30℃; for 12h; pH=6.7; Kinetics; Concentration; aq. buffer; Enzymatic reaction;A 6 %Chromat.
B 5 %Chromat.
C 52 %Chromat.
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

Benz-phenylimidsaeure-triaethylsilylester
18663-30-4

Benz-phenylimidsaeure-triaethylsilylester

1-(triethylsiloxy)-1-isopropyl-4-methyl-3-cyclohexane

1-(triethylsiloxy)-1-isopropyl-4-methyl-3-cyclohexane

Conditions
ConditionsYield
With pyridinium triflate In tetrahydrofuran at 25℃; for 0.166667h;99%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

tert-butyldimethylsilyl N-phenylbenzimidate
404392-70-7

tert-butyldimethylsilyl N-phenylbenzimidate

1-(tert-butyldimethylsilyloxy)-1-isopropyl-4-methyl-3-cyclohexene

1-(tert-butyldimethylsilyloxy)-1-isopropyl-4-methyl-3-cyclohexene

Conditions
ConditionsYield
With pyridinium triflate In tetrahydrofuran at 50℃; for 2.5h;96%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

C16H19NOSi
96622-71-8

C16H19NOSi

(1-isopropyl-4-methyl-cyclohex-3-enyloxy)-trimethyl-silane

(1-isopropyl-4-methyl-cyclohex-3-enyloxy)-trimethyl-silane

Conditions
ConditionsYield
With pyridinium triflate In tetrahydrofuran at 25℃; for 0.0833333h;95%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

anilino(tert-butyldimethyl)silane
53742-62-4

anilino(tert-butyldimethyl)silane

1-(tert-butyldimethylsilyloxy)-1-isopropyl-4-methyl-3-cyclohexene

1-(tert-butyldimethylsilyloxy)-1-isopropyl-4-methyl-3-cyclohexene

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In N,N-dimethyl-formamide at 20℃; for 3h;92%
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

C15H26O2

C15H26O2

Conditions
ConditionsYield
With N.N'-bis[3,5-bis(trifluoromethyl)phenyl]thiourea at 50℃; for 51h;92%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

1,1,1-triethyl-N-phenylsilanamine
18106-48-4

1,1,1-triethyl-N-phenylsilanamine

1-(triethylsiloxy)-1-isopropyl-4-methyl-3-cyclohexane

1-(triethylsiloxy)-1-isopropyl-4-methyl-3-cyclohexane

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In N,N-dimethyl-formamide at 20℃; for 0.5h;91%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

acetic anhydride
108-24-7

acetic anhydride

α-terpinenyl acetate
4821-04-9

α-terpinenyl acetate

Conditions
ConditionsYield
With C12H8N2*2CH4O3S at 40℃; for 5h;89%
With sodium acetate In xylene
With pyridine In dichloromethane Acetylation;
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

1,2-dibromomethane
74-95-3

1,2-dibromomethane

3-isopropyl-6-methylbicyclo[4.1.0]heptan-3-ol

3-isopropyl-6-methylbicyclo[4.1.0]heptan-3-ol

Conditions
ConditionsYield
Stage #1: TERPINEN-4-OL With tert-butylmagnesium chloride In tetrahydrofuran; diethyl ether Cooling; Inert atmosphere;
Stage #2: 1,2-dibromomethane With tert-butylmagnesium chloride In tetrahydrofuran; diethyl ether at 20℃; for 2h; Inert atmosphere; optical yield given as %de;
89%
With tert-butylmagnesium chloride In diethyl ether at 25℃; for 16h;85%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

2-bromo-2-methyl-N-phenylpropanamide
2322-45-4

2-bromo-2-methyl-N-phenylpropanamide

2-((1-isopropyl-4-methylcyclohex-3-en-1-yl)oxy)-2-methyl-N-phenylpropanamide

2-((1-isopropyl-4-methylcyclohex-3-en-1-yl)oxy)-2-methyl-N-phenylpropanamide

Conditions
ConditionsYield
With caesium carbonate In acetonitrile at 20℃; for 18h; Inert atmosphere;82%
With potassium phosphate; copper(I) bromide dimethylsulfide complex; tricyclohexylphosphine In acetonitrile at 80℃; for 24h;48%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

1-chloro-3,3,4,4,5-pentamethyl-2-oxa-3-silahexane
125816-34-4

1-chloro-3,3,4,4,5-pentamethyl-2-oxa-3-silahexane

(1-Isopropyl-4-methyl-cyclohex-3-enyloxymethoxy)-dimethyl-(1,1,2-trimethyl-propyl)-silane
125816-48-0

(1-Isopropyl-4-methyl-cyclohex-3-enyloxymethoxy)-dimethyl-(1,1,2-trimethyl-propyl)-silane

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane for 45h; Ambient temperature;80%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

(1R,3R,6S)-3-Isopropyl-6-methyl-7-oxa-bicyclo[4.1.0]heptan-3-ol

(1R,3R,6S)-3-Isopropyl-6-methyl-7-oxa-bicyclo[4.1.0]heptan-3-ol

Conditions
ConditionsYield
With dihydrogen peroxide; dicyclohexyl-carbodiimide In water Ambient temperature; other reagent: H2O2/KHCO3/benzonitrile;80%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

1-isopropyl-4-methylcyclohexane-1,4-diol
1753-42-0

1-isopropyl-4-methylcyclohexane-1,4-diol

Conditions
ConditionsYield
With iron(III)-acetylacetonate; methyl 4-nitrobenzenesulfonate; phenylsilane; sodium hydrogencarbonate In methanol at 0 - 20℃; for 12h; Schlenk technique; Inert atmosphere; diastereoselective reaction;76%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

2-hydroxy-1,4-cineole
22621-68-7

2-hydroxy-1,4-cineole

Conditions
ConditionsYield
With dihydrogen peroxide In chloroform at 25℃; for 0.5h; Concentration; Solvent; Temperature;70.1%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

methyl iodide
74-88-4

methyl iodide

4-isopropyl-4-methoxy-1-methylcyclohex-1-ene
94281-60-4

4-isopropyl-4-methoxy-1-methylcyclohex-1-ene

Conditions
ConditionsYield
With potassium tert-butylate In diethyl ether at 20℃; for 72h; Schlenk technique;60%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

D-glucal triacetate
2873-29-2

D-glucal triacetate

α-terpinyl 4,6-di-O-acetyl-2,3-dideoxy-α-D-erythro-hex-2-enopyranoside
1619941-96-6

α-terpinyl 4,6-di-O-acetyl-2,3-dideoxy-α-D-erythro-hex-2-enopyranoside

Conditions
ConditionsYield
With zinc dibromide In chloroform at 72℃; for 0.916667h; Ferrier Carbohydrate Rearrangement; Microwave irradiation; stereoselective reaction;56%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

methyl 4-terpinyl carbonate
1262126-86-2

methyl 4-terpinyl carbonate

Conditions
ConditionsYield
Stage #1: carbonic acid dimethyl ester With lanthanum(III) isopropoxide; 2-(2-methoxyethoxy)ethyl alcohol at 20℃;
Stage #2: TERPINEN-4-OL for 89h; Reflux; chemoselective reaction;
55%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

A

3,4-cis-Epoxy-1-isopropyl-4-methylcyclohexan-1-ol

3,4-cis-Epoxy-1-isopropyl-4-methylcyclohexan-1-ol

B

para-menthane-1,2,4-triol
98109-59-2

para-menthane-1,2,4-triol

Conditions
ConditionsYield
With 3-Methylpyrazole; dihydrogen peroxide; methyltrioxorhenium(VII) at 10 - 20℃; for 2h;A n/a
B 42%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide
572-09-8

2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide

1-p-Menthen-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosid
99049-84-0, 99049-85-1

1-p-Menthen-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosid

Conditions
ConditionsYield
With molecular sieve; silver silicate In dichloromethane for 48h; Ambient temperature;21%
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

1,4-dibromo-p-menthane
25570-96-1

1,4-dibromo-p-menthane

Conditions
ConditionsYield
With hydrogen bromide; acetic acid trans-form;
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

1,4-dichloro-p-menthane
27621-71-2

1,4-dichloro-p-menthane

Conditions
ConditionsYield
With hydrogenchloride; acetic acid trans-form;
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

1,4-dichloro-trans-p-menthane
25570-95-0

1,4-dichloro-trans-p-menthane

Conditions
ConditionsYield
With hydrogenchloride; acetic acid
TERPINEN-4-OL
562-74-3

TERPINEN-4-OL

cis-p-menthan-4-ol
3239-02-9

cis-p-menthan-4-ol

Conditions
ConditionsYield
With nickel at 125 - 130℃; under 5884.06 Torr; Hydrogenation;
With (bis-1,2-diphenylphosphinoethane)Co(CH2SiMe3)2; hydrogen In toluene at -196.15 - 25℃; under 3040.2 Torr; for 4h; Reagent/catalyst; Sealed tube; diastereoselective reaction;n/a
With C54H57F3N4O6RuS; hydrogen In dichloromethane at 80℃; under 37503.8 Torr; for 13h; Reagent/catalyst; Inert atmosphere; Sealed tube;
With hydrogen In toluene at 80℃; under 2250.23 Torr; Catalytic behavior; Activation energy; Reagent/catalyst; Temperature; Autoclave; diastereoselective reaction;n/a

562-74-3Relevant articles and documents

Synthesis of Terpineol from Alpha-Pinene Catalyzed by α-Hydroxy Acids

Hu, Yi-Ming,Huang, Xiao-Rui,Meng, Zhong-Lei,Qin, Rong-Xiu,Wen, Ru-Si,Zhou, Yong-Hong

, (2022/02/17)

We report the use of five alpha-hydroxy acids (citric, tartaric, mandelic, lactic and glycolic acids) as catalysts in the synthesis of terpineol from alpha-pinene. The study found that the hydration rate of pinene was slow when only catalyzed by alpha-hydroxyl acids. Ternary composite catalysts, composed of AHAs, phosphoric acid, and acetic acid, had a good catalytic performance. The reaction step was hydrolysis of the intermediate terpinyl acetate, which yielded terpineol. The optimal reaction conditions were as follows: alpha-pinene, acetic acid, water, citric acid, and phosphoric acid, at a mass ratio of 1:2.5:1:(0.1–0.05):0.05, a reaction temperature of 70? C, and a reaction time of 12–15 h. The conversion of alpha-pinene was 96%, the content of alpha-terpineol was 46.9%, and the selectivity of alpha-terpineol was 48.1%. In addition, the catalytic performance of monolayer graphene oxide and its composite catalyst with citric acid was studied, with acetic acid used as an additive.

PROCESS FOR PREPARING A MIXTURE OF TERPENE ALCOHOLS

-

Page/Page column 13, (2017/09/15)

The present invention relates to a process for preparing a mixture of terpene alcohols comprising limonene-4-ol and terpinene-4-ol from terpinolene epoxide via an isomerization and/or hydrogenation reaction in the presence of a copper catalyst.

PROCESS FOR PREPARING TERPINENE-4-OL

-

Page/Page column 9; 10; 11, (2017/09/09)

The present invention relates to a process for preparing terpinene-4-ol from limonene-4-ol via a hydrogenation reaction in the presence of a nickel catalyst.

Biotransformations of terpenes by fungi from amazonian Citrus plants

Moreno Rueda, Maria Gabriela,Guerrini, Alessandra,Giovannini, Pier Paolo,Medici, Alessandro,Grandini, Alessandro,Sacchetti, Gianni,Pedrini, Paola

, p. 1909 - 1919 (2013/11/06)

The biotransformations of (RS)-linalool (1), (S)-citronellal (2), and sabinene (3) with fungi isolated from the epicarp of fruits of Citrus genus of the Amazonian forest (i.e., C. limon, C. aurantifolia, C. aurantium, and C. paradisiaca) are reported. The

Cloning and characterization of Pfl-1841, a 2-methylenebornane synthase in Pseudomonas fluorescens PfO-1

Chou, Wayne K.W.,Ikeda, Haruo,Cane, David E.

supporting information; experimental part, p. 6627 - 6632 (2011/10/04)

The pfl-1841 gene from Pseudomonas fluorescens PfO-1 is the only gene in any of the three sequenced genomes of the Gram-negative bacterium P. fluorescens, that is, annotated as a putative terpene synthase. The predicted Pfl-1841 protein, which harbors the two strictly conserved divalent metal binding domains found in all terpene cyclases, is closely related to several known or presumed 2-methylisoborneol synthases, with the closest match being to the MOL protein of Micromonaspora olivasterospora KY11048 that has been implicated as a 2-methylenebornane synthase. A synthetic gene encoding P. fluorescens Pfl-1841 and optimized for expression in Escherichia coli was expressed and purified as an N-terminal His6-tagged protein. Incubation of recombinant Pfl-1841 with 2-methylgeranyl diphosphate produced 2-methylenebornane as the major product accompanied by 1-methylcamphene as well as other minor, monomethyl-homomonoterpene hydrocarbons and alcohols. The steady-state kinetic parameters for the Pfl-1841-catalyzed reaction were K M=110±13 nM and kcat=2.4±0.1×10 -2 s-1. Attempts to identify the P. fluorescens SAM-dependent 2-methylgeranyl diphosphate synthase have so far been unsuccessful.

A facile method for the rapid and selective deprotection of methoxymethyl (MOM) ethers

Han, Jae Hyun,Kwon, Young Eun,Sohn, Jeong-Hun,Ryu, Do Hyun

experimental part, p. 1673 - 1677 (2010/04/04)

We describe a rapid and efficient method for selective deprotection of methoxymethyl (MOM) ethers using ZnBr2 and n-PrSH, which completely removed MOM from diverse MOM ethers of primary, secondary, and tertiary alcohols or phenol derivatives. The deprotection takes less than ten minutes with both high yield and selectivity in the presence of other protecting groups. In addition, the rapid deprotection of MOM ethers of tertiary hydroxyls in high yield with no epimerization allows MOM to be a suitable protecting group for tertiary alcohols.

Lithium-potassium superbases as key reagents for the base-catalysed isomerisation of some terpenoids

Deagostino,Tivola,Prandi,Venturello

, p. 2856 - 2860 (2007/10/03)

Some representative monoterpenes have been isomerised under the influence of Schlosser's lithium-potassium mixed superbases, promoting β-elimination reactions. The results are compared with those obtained with butyllithium and LDA. Different selectivities and different reaction yields are achieved as a function of the base employed. These results confirm the particular reactivity of bimetallic reagents. In this paper it is proposed that the observed selectivities might depend on the conformational features of the substrate, on the strength of the organometallic reagent, as well as on steric requirements of the elimination reaction.

Base-catalysed rearrangement of p-menth-1-en-4(8)-oxide

Roy, Animesh,Gurudutt, K. N.,Rao, Sanjay

, p. 636 - 638 (2007/10/03)

p-Menth-1-en-4(8)-oxide (1), a tetrasubstituted spiro epoxide is normally resistant towards bases but under forcing condition with AIP rearranges to p-mentha-1,8-dien-4-ol (2).On the other hand, with t-BuOK, p-mentha-1,3-dien-8-ol (3) and p-mentha-1,4-dien-8-ol (4) are formed as the major products.These compounds readily get oxidised to p-cymen-8-ol (5), as seen in the reaction of 1 with N-LiEDA.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 562-74-3